期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

EZH2和Ki67蛋白在膀胱移行细胞癌中的表达及意义 被引量：2

Expression and significance of EZH2 and Ki67 in human bladder transitional cell carcinoma
下载PDF
导出
摘要 目的研究EZH2和Ki67蛋白在膀胱癌组织中的表达及其临床意义。方法采用免疫组化法对72例膀胱癌患者癌组织中的EZH2和Ki67蛋白进行测定。结果膀胱癌组织中EZH2及Ki67蛋白阳性率显著高于膀胱正常黏膜组织,差异有统计学意义(P<0.05)。结论 EZH2蛋白表达增高与膀胱癌的临床分期,复发密切相关,并与Ki67正相关。联合检测EZH2及Ki67可以作为反映膀胱癌预后的生物学因子。 Objective To study the clinical significance and expression of EZH2 and Ki67 in human bladder transitional cell carcinoma（BTCC）.Methods 72 cases of in BTCC were evaluated for EZH2 and Ki67 protein expression by immunohistochemical method.Results The positive expression level of EZH2 and Ki67 in BTCC which were higher than that in normal bladder transitional cell.The difference was significant（P0.05）.Conclusion Increased expression of EZH2 is correlated with cell clinical classification and recrudescence of BTCC,and positive correlated with the expression of Ki67.Detection of EZH2 and Ki67 can be used as a biological factor to reflect the prognosis of BTCC.
作者 徐松涛 邵雪峰 蒋挺 刘锋
机构地区 江苏省太仓市第一人民医院泌尿外科
出处 《中国现代医药杂志》 2010年第11期72-74,共3页 Modern Medicine Journal of China
关键词 膀胱癌 EZH2 KI67 Bladder carcinoma EZH2 Ki67
分类号 R737.14 [医药卫生—肿瘤]
  • 相关文献

参考文献2

二级参考文献14

  • 1郑骏年,马腾骧,孙晓青,陈家存,温儒民,曹敬毅,杨文发,李望,刘俊杰.Ki-67基因siRNA表达质粒的构建、鉴定及功能研究[J].中华实验外科杂志,2005,22(5):611-613. 被引量：11
  • 2[1]Moriki T,Takahashi T,Hiroi M,et al.Histological grade in invasive ductal carcinoma of breast correlates with the proliferative activity evaluated by BrdU:aninunohistochemical study including correlations with p53 CerbB-2 and estrogen receptor status.Pathol Int,1996,46:417-425
  • 3[2]Soomro S,Taylor P,Shepard HM,et al.CerbB-2 expression in different histological types of invasive breast careinoma.J Clin Pathol,1991,44:21
  • 4[4]Hall PA.Proliferating cell unclear antigen (PCNA)immunoloc.alization in paraffin sections:an index of cell proliferation with evidence of deregulated expression in some neoplasms[J].J Pathol,1990,162(4):285-288.
  • 5[5]Pinder SE,Wencky P,Sibbering DM,et al.Assessment of the new proliferation nmrker M IB1 in breast carcinoma using image analysis:association with other prognostic factors and survival[j].Br jCancer,1995,71(2):146 150
  • 6[6]RamiresM,David L,LeitaoD,etal.Ki67labelling indexin gastric carcinomasl[J].J Pathology,1997,182(1):62-67
  • 7[7]Raybaud-Diogene H,Fortin A,Morency R,et al.Markers of Radioresistance in squamous cell carcinoma s of the Head and Neck:AClinicopathologic and Immunohistochemical study-J J.J Clin Oncology,1997.15(3):1030-1038
  • 8[8]Liu SC,Edwand RS,Marie LC,et al.Markers of cell proliferation in normal epithelia and dysplastic dysplastic leukoplakias of the oral cavity[J].Cancer Epideminol Biota Prevention,1998,7(5):598-603
  • 9[9]Niewiadomska H,Jeziorski A,O Borski B.The expression of the proliferating antigen Ki67,PCNA and products of suppressor gene p53 in primary invasive ductal breast carcinoma[J].J Exp Clin Cancer Res,1998,17(4):503-510
  • 10Brummelkamp TR, Bernards R, Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell, 2002, 2:243-247.

共引文献17

同被引文献29

  • 1方静,薛艳,周党侠,苟文丽.EZH2基因在宫颈癌中的表达及其意义[J].西安交通大学学报（医学版）,2011,32(6):758-760. 被引量：10
  • 2谢丽,安瑞芳,王姝,薛艳.Ki-67蛋白在妊娠滋养细胞疾病中表达的意义[J].现代肿瘤医学,2007,15(7):1001-1003. 被引量：3
  • 3董桂兰,张小楠,袁文棋.EZH2和p53在乳腺癌中的表达及相关性探讨[J].中国肿瘤临床,2007,34(16):931-933. 被引量：20
  • 4Margueron R, Reinberq D. The Polycomb complex PRC2 and its mark in life[J]. Nature, 2011,469(7330) :343-349. DOI: 10. 1038/nature09784.
  • 5Cardoso C, Mignon C, Hetet G, et al. The human EZH2 gene : genomic organisatin and revised mapping in 7q35 within the criti- cal region for malignant myeloid disorders[J]. Eur J Hum Genet- ics,2000,8(3) :174-180. DOI:10. 1038/sj. ejhg. 5200439.
  • 6Margueron R,Li G,Sarma K,et al. EZH1 and EZH2 maintain re- pressive chromatin throughe different mechanisms [ J ]. Mol Cell, 2008,32(4) :503-518. DOI: 10. 1016/j. molCel. 2008.11. 004.
  • 7Hillier LW, Fulton RS, Fulton LA, et al. The DNA sequence of human chromosome 7 [ J ]. Nature, 2003,10 ; 424 ( 6945 ) : 157- 164. DOI:10. 1038/nature01782.
  • 8Kim W, Bird GH, Neff T, et al. Target disruption of the EZH2- EED complex inhibits EZH2-dependent cancer [ J ]. Nature Chemical Biology, 2013, 9 (10) : 643-650. DOI: 10. 1038/ nchembio. 1331.
  • 9Lessard J1, Sauvageau G. Polycomb group genes as epigenetic regulators of normal and leukemic hemopoiesis[ J]. Exp Hematol, 2003,31 ( 7 ) :567-585. DOI. 10. 1016/S0301-472X ( 03 ) 00081 - X.
  • 10Hock H. A complex polycomb issue: the two faces EZH2 in canc- er[J]. Genes Dev, 2012,26(8) :751-755. DOI: 10. ll01/gad.191163. 112.

引证文献2

中国现代医药杂志
2010年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部